Display options
Share it on

J Geriatr Cardiol. 2012 Dec;9(4):401-7. doi: 10.3724/SP.J.1263.2011.12282.

High density lipoproteins and atherosclerosis: emerging aspects.

Journal of geriatric cardiology : JGC

Federica Sala, Alberico Luigi Catapano, Giuseppe Danilo Norata

Affiliations

  1. Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, Milan 20133, Italy.

PMID: 23341845 PMCID: PMC3545258 DOI: 10.3724/SP.J.1263.2011.12282

Abstract

High density lipoproteins (HDL) promote the efflux of excess cholesterol from peripheral tissues to the liver for excretion. This ability is responsible for the most relevant anti-atherogenic effect of HDL. The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. Furthermore, during inflammation, the composition of this class of lipoproteins varies to a large extent, thus promoting the formation of dysfunctional HDL. The aim of this review is to discuss the emerging role of HDL in modulating the activity of immune cells and immune-inflammatory mediators during atherogenesis.

Keywords: Apolipoprotein; High density lipoproteins; Immune response; Sphingosine-1-phosphate

References

  1. J Lipid Res. 1989 Jan;30(1):39-49 - PubMed
  2. Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):541-7 - PubMed
  3. Science. 2007 Apr 13;316(5822):295-8 - PubMed
  4. J Exp Med. 1994 Sep 1;180(3):1025-35 - PubMed
  5. Cell. 2001 Feb 23;104(4):503-16 - PubMed
  6. Circ Res. 2005 Aug 5;97(3):236-43 - PubMed
  7. Trends Cardiovasc Med. 2010 Feb;20(2):35-40 - PubMed
  8. Curr Opin Lipidol. 2002 Aug;13(4):373-81 - PubMed
  9. Cell. 2008 Jul 11;134(1):97-111 - PubMed
  10. J Clin Invest. 1981 Dec;68(6):1503-13 - PubMed
  11. Circulation. 2007 Jan 30;115(4):501-8 - PubMed
  12. Circulation. 2009 Mar 3;119(8):1135-45 - PubMed
  13. Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1724-31 - PubMed
  14. Scand J Immunol. 2006 Jan;63(1):7-16 - PubMed
  15. J Biol Chem. 1998 Feb 13;273(7):4012-20 - PubMed
  16. Semin Cell Dev Biol. 2007 Oct;18(5):616-26 - PubMed
  17. Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1832-41 - PubMed
  18. J Clin Invest. 2008 Jan;118(1):364-75 - PubMed
  19. Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):607-13 - PubMed
  20. Trends Cardiovasc Med. 2001 Apr-May;11(3-4):155-61 - PubMed
  21. J Leukoc Biol. 2003 Jul;74(1):40-8 - PubMed
  22. Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2071-7 - PubMed
  23. N Engl J Med. 2011 Jan 13;364(2):127-35 - PubMed
  24. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12040-4 - PubMed
  25. Curr Opin Lipidol. 2011 Oct;22(5):410-6 - PubMed
  26. J Biol Chem. 2006 Nov 24;281(47):36091-101 - PubMed
  27. Nat Immunol. 2005 Dec;6(12):1198-205 - PubMed
  28. FASEB J. 2008 Dec;22(12):4044-54 - PubMed
  29. Eur J Immunol. 2000 Mar;30(3):954-63 - PubMed
  30. J Immunol. 2003 Feb 1;170(3):1329-38 - PubMed
  31. Prostaglandins Other Lipid Mediat. 2006 Mar;79(1-2):1-33 - PubMed
  32. J Biol Chem. 2010 Nov 12;285(46):36158-69 - PubMed
  33. Arterioscler Thromb Vasc Biol. 2008 May;28(5):925-31 - PubMed
  34. J Lipid Res. 1985 Dec;26(12):1389-98 - PubMed
  35. Nat Immunol. 2010 Nov;11(11):1047-56 - PubMed
  36. Atherosclerosis. 1998 Aug;139(2):307-15 - PubMed
  37. N Engl J Med. 1999 Jan 14;340(2):115-26 - PubMed
  38. Curr Opin Immunol. 2004 Feb;16(1):103-7 - PubMed
  39. J Clin Invest. 2007 Aug;117(8):2216-24 - PubMed
  40. Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):13-27 - PubMed
  41. Am J Physiol. 1999 Jul;277(1):R94-103 - PubMed
  42. Atherosclerosis. 2012 Jan;220(1):11-21 - PubMed
  43. J Biol Chem. 1986 Jul 25;261(21):9644-51 - PubMed
  44. Nat Rev Immunol. 2008 Oct;8(10):776-87 - PubMed
  45. Semin Cell Dev Biol. 2007 Oct;18(5):608-15 - PubMed
  46. Prog Lipid Res. 2006 May;45(3):187-202 - PubMed
  47. J Lipid Res. 1997 Apr;38(4):634-44 - PubMed
  48. J Lipid Res. 2004 Jun;45(6):993-1007 - PubMed
  49. Nature. 2000 Sep 14;407(6801):233-41 - PubMed
  50. Mol Membr Biol. 2006 Jan-Feb;23(1):49-57 - PubMed
  51. Blood. 2005 Nov 1;106(9):3074-81 - PubMed
  52. Circ Shock. 1993 May;40(1):14-23 - PubMed
  53. J Lipid Res. 2004 Jul;45(7):1169-96 - PubMed
  54. Biochem Biophys Res Commun. 2005 Dec 16;338(2):1126-36 - PubMed
  55. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9 - PubMed
  56. Clin Immunol. 2010 Jan;134(1):25-32 - PubMed
  57. Annu Rev Immunol. 2003;21:457-81 - PubMed
  58. Science. 2010 Jun 25;328(5986):1641-2 - PubMed
  59. Nat Immunol. 2010 Apr;11(4):328-34 - PubMed
  60. J Clin Invest. 1995 Dec;96(6):2758-67 - PubMed
  61. Science. 2002 Apr 12;296(5566):346-9 - PubMed
  62. FEBS Lett. 2008 Nov 12;582(27):3711-8 - PubMed
  63. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1876-90 - PubMed
  64. Circulation. 2009 Aug 25;120(8):699-708 - PubMed
  65. Diabetes. 2009 Dec;58(12):2711-7 - PubMed
  66. Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):843-9 - PubMed
  67. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1153-8 - PubMed
  68. J Lipid Res. 1995 May;36(5):1058-65 - PubMed
  69. Nat Immunol. 2011 Mar;12(3):204-12 - PubMed
  70. Cardiovasc Res. 1998 Mar;37(3):799-810 - PubMed
  71. Shock. 1997 Mar;7(3):175-81 - PubMed
  72. Nat Immunol. 2000 Aug;1(2):156-62 - PubMed
  73. Science. 2010 Jun 25;328(5986):1689-93 - PubMed
  74. Coron Artery Dis. 2007 Nov;18(7):523-31 - PubMed
  75. Circ Res. 2010 Mar 5;106(4):720-9 - PubMed
  76. Infect Immun. 1985 Oct;50(1):73-6 - PubMed

Publication Types